Affiliation: National Institutes of Health
- Racial and ethnic disparities in end-stage kidney failure-survival paradoxes in African-AmericansLawrence Agodoa
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA
Semin Dial 20:577-85. 2007..A successful renal transplant improves but does not restore the expected remaining life times. Therefore, aggressive approach is required in investigating the factors that confer such high mortality risk on ESRD patients...
- Lessons from chronic renal diseases in African Americans: treatment implicationsLawrence Agodoa
Office of Minority Health Research Coordination, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892 5454, USA
Ethn Dis 13:S118-24. 2003....
- Racial differences and income disparities are associated with poor outcomes in kidney transplant recipients with lupus nephritisRobert Nee
Nephrology, Walter Reed National Military Medical Center, 8901 Wisconsin Avenue, Bethesda, MD 20889, USA
Transplantation 95:1471-8. 2013..We analyzed the United States Renal Data System database to assess the impact of these disparities on graft loss and death in the LN and non-LN cohorts...
- Acute renal failure in the PACULawrence Agodoa
End Stage Renal Disease, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA
J Perianesth Nurs 17:377-83. 2002..Large-scale, prospective, randomized clinical trials in the PACU setting are needed to determine the most effective management plan. This is a U.S. government work. There are no restrictions on its use...
- Risk of intracranial hemorrhage associated with autosomal dominant polycystic kidney disease in patients with end stage renal diseaseDavid J Yoo
Nephrology, Walter Reed National Military Medical Center, 8901 Wisconsin Ave, Bethesda, MD, USA
BMC Nephrol 15:39. 2014..It is often assumed that patients with ADPKD are not at increased risk of ICH after starting dialysis. We hypothesized that patients with ADPKD would have a higher subsequent risk of ICH even after the start of chronic dialysis...
- Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppressionSophie Caillard
Nephrology Service, Walter Reed Army Medical Center, Washington, DC 20307 5001, and Uniformed Services University of the Health Sciences, Bethesda, MD, USA
Transplantation 80:1233-43. 2005..Posttransplant lymphoproliferative disorders (PTLD) still represent a major preoccupation after renal transplantation, even in the most recent years...
- Association of serum albumin and atherosclerosis in chronic hemodialysis patientsSrinivasan Beddhu
National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA
Am J Kidney Dis 40:721-7. 2002..Because cardiovascular disease is the leading cause of death and hypoalbuminemia predicts mortality, hypoalbuminemia may be associated with atherosclerosis...
- Excerpts from the United States Renal Data System 2007 annual data reportAllan J Collins
Am J Kidney Dis 51:S1-320. 2008
- The role of anemia management in improving outcomes for African-Americans with chronic kidney diseaseJanice P Lea
Department of Medicine, Renal Division, Emory University, Atlanta, Georgia 30308, USA
Am J Nephrol 28:732-43. 2008..This review explores racial-specific challenges and potential solutions in renal anemia management to improve outcomes in African-American patients...
- Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United StatesAllan J Collins
Am J Kidney Dis 45:A5-7, S1-280. 2005
- Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New ZealandJohn H Stewart
Department of Medical and Surgical Sciences, University of Otago, Dunedin, New Zealand
J Am Soc Nephrol 14:197-207. 2003....
- Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United StatesAllan J Collins
Am J Kidney Dis 42:A5-7, S1-230. 2003
- Racial disparities in renal replacement therapyCrystal Gadegbeku
Medical University of South Carolina, Charleston, USA
J Natl Med Assoc 94:45S-54S. 2002....
- Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK)Jennifer J Gassman
Cleveland Clinic Department of Biostatistics, Ohio, 44195, USA
J Am Soc Nephrol 14:S154-65. 2003..The main secondary patient outcome is a composite including the following events: (1) reduction in GFR by 50%, (2) end-stage renal disease, or (3) death...
- Racial disparities in kidney health: the puzzle to solveLawrence Agodoa
Am J Kidney Dis 40:1337-9. 2002
- Association of incident gout and mortality in dialysis patientsScott D Cohen
Division of Renal Diseases, Department of Medicine, George Washington University Medical Center, Washington DC, USA
J Am Soc Nephrol 19:2204-10. 2008..5-fold increase in mortality risk (adjusted hazard ratio 1.49; 95% confidence interval 1.43 to 1.55). The mechanisms underlying this association require further study...
- Metabolic syndrome, proteinuria, and the risk of progressive CKD in hypertensive African AmericansJanice Lea
Emory University, Atlanta, GA 30322, USA
Am J Kidney Dis 51:732-40. 2008..The purpose of this study is to examine whether metabolic syndrome is associated with kidney disease progression in hypertensive African Americans...
- Ethnic disparities in the prevalence and treatment of kidney diseaseSusanne Nicholas
David Geffen School of Medicine, University of California at Los Angeles, USA
Nephrol News Issues 18:29-30, 32, 34 passim. 2004
- Excerpts from the United States Renal Data System 2006 Annual Data ReportAllan J Collins
Am J Kidney Dis 49:A6-7, S1-296. 2007
- Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO studyAlfred K Cheung
VA Salt Lake City Healthcare System and Department of Medicine, University of Utah, Salt Lake City, Utah 84112, USA
J Am Soc Nephrol 17:546-55. 2006..05 to 1.19; P = 0.001), after adjustment for residual kidney urea clearance and number of prestudy years on dialysis. This association is supportive of the potential value of beta(2)M as a marker to guide chronic hemodialysis therapy...
- Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO studyAlfred K Cheung
Veterans Affairs Salt Lake City Healthcare System and Department of Medicine, University of Utah, Salt Lake City, Utah 84112, USA
J Am Soc Nephrol 14:3251-63. 2003..The subgroup results that demonstrate that patients with different durations of dialysis are affected differently by high-flux dialysis are interesting and require further study for confirmation...
- Successful blood pressure control in the African American Study of Kidney Disease and HypertensionJackson T Wright
Department of Medicine, Division of Hypertension, Case Western Reserve University, 10900 Euclid Ave, Wood Bldg, Room W 165, Cleveland, OH 44106 4982, USA
Arch Intern Med 162:1636-43. 2002..The African American Study of Kidney Disease and Hypertension (AASK) is an ongoing trial to evaluate the effect of blood pressure and choice of antihypertensive drug on the rate of decline of renal function...